EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.B41 | gene SIRT6, transient overexpression of FLAG-tagged SIRT6 in HeLa cells, quantitative reverse transcription PCR enzyme expression analysis | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.B41 | additional information | specific downregulation of histone deacetylase sirtuin 6 (SIRT6), overexpression of SIRT6. In Hep-G2 cells, doxorubicin treatment results in significant increases in SIRT1 and SIRT4 mRNA expression and downregulation of SIRT6 mRNA level by 36 h | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | NAD+ + [protein]-N6-palmitoyl-L-lysine | Homo sapiens | - |
nicotinamide + [protein]-L-lysine + 2'-O-palmitoyl-ADP ribose | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.B41 | Homo sapiens | Q8N6T7 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.B41 | Hep-G2 cell | - |
Homo sapiens | - |
2.3.1.B41 | hepatoma cell | - |
Homo sapiens | - |
2.3.1.B41 | Huh-7 cell | - |
Homo sapiens | - |
2.3.1.B41 | liver | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | NAD+ + [protein]-N6-palmitoyl-L-lysine | - |
Homo sapiens | nicotinamide + [protein]-L-lysine + 2'-O-palmitoyl-ADP ribose | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.B41 | histone deacetylase | - |
Homo sapiens |
2.3.1.B41 | SIRT6 | - |
Homo sapiens |
2.3.1.B41 | sirtuin 6 | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.B41 | NAD+ | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.3.1.B41 | Homo sapiens | in Hep-G2 cells, doxorubicin treatment results in significant increases in SIRT1 and SIRT4 mRNA expression and downregulation of SIRT6 mRNA level by 36 h | down |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.B41 | malfunction | downregulation of SIRT6 enables forkhead box O3 (FOXO3) upregulation, translocation into the nucleus, and increased expression of its target genes p27 and Bim, which further induce apoptosis. Overexpression of SIRT6, but not enzyme-inactivated mutants, prevents FOXO3 translocation into the nucleus and doxorubicin-induced cell death | Homo sapiens |
2.3.1.B41 | physiological function | histone deacetylase SIRT6, one of the SIRT proteins, plays critical roles in controlling metabolism, genomic stability, inflammation, aging and cancer progression. SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity. SIRT6 interacts with FOXO3 and this interaction increases FOXO3 ubiquitination and decreases its stability. The effect of SIRT6 in preventing doxorubicin-induced cell death requires FOXO3. Overexpression of SIRT6 could not prevent doxorubicin-induced cell death in FOXO3 knockdown cells. SIRT6 plays a central role in determining doxorubicin-induced cell death via modulation of FOXO3 activity | Homo sapiens |